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Abstract
In regions without complete-coverage civil registration and vital statistics systems there is 
uncertainty about even the most basic demographic indicators. In such regions the majority of 
deaths occur outside hospitals and are not recorded. Worldwide, fewer than one-third of deaths are 
assigned a cause, with the least information available from the most impoverished nations. In 
populations like this, verbal autopsy (VA) is a commonly used tool to assess cause of death and 
estimate cause-specific mortality rates and the distribution of deaths by cause. VA uses an 
interview with caregivers of the decedent to elicit data describing the signs and symptoms leading 
up to the death. This paper develops a new statistical tool known as InSilicoVA to classify cause of 
death using information acquired through VA. InSilicoVA shares uncertainty between cause of 
death assignments for specific individuals and the distribution of deaths by cause across the 
population. Using side-by-side comparisons with both observed and simulated data, we 
demonstrate that InSilicoVA has distinct advantages compared to currently available methods.
1 Introduction
Data describing cause of death are critical to formulate, implement and evaluate public 
health policy. Fewer than one-third of deaths worldwide are assigned a cause, with the most 
impoverished nations having the least information (Horton, 2007). In 2007 The Lancet 
published a special issue titled “Who Counts?” (AbouZahr et al., 2007; Boerma and Stansfi, 
2007; Hill et al., 2007; Horton, 2007; Mahapatra et al., 2007; Setel et al., 2007); the authors 
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identify the “scandal of invisibility” resulting from the lack of accurate, timely, full-coverage 
civil registration and vital statistics systems in much of the developing world. They argue for 
a transformation in how civil registration is conducted in those parts of the world so that we 
are able to monitor health and design and evaluate effective interventions in a timely way. 
Horton (2007) argues that the past four decades have seen “little progress” and “limited 
attention to vital registration” by national and international organizations. With bleak 
prospects for widespread civil registration in the coming decades, AbouZahr et al. (2007) 
recommends “censuses and survey-based approaches will have to be used to obtain the 
population representative data.” This paper develops a statistical method for analyzing data 
based on one such survey. The proposed method infers a likely cause of death for a given 
individual, while simultaneously estimating a population distribution of deaths by cause. 
Individual deaths by cause can be related to surviving family members, while the population 
distribution of deaths provides critical information about the leading risks to population 
health. Critically, the proposed method also provides a statistical framework for quantifying 
uncertainty in such data.
1.1 Verbal autopsy
We propose a method for using survey-based data to infer an individual’s cause of death and 
a distribution of deaths by cause for the population. The data are derived from verbal 
autopsy (VA) interviews. VA is conducted by administering a standardized questionnaire to 
caregivers, family members and/or others knowledgeable of the circumstances of a recent 
death. The resulting data describe the decedent’s health history leading up to death with a 
mixture of binary, numeric, categorical and narrative data. These data describe the sequence 
and duration of important signs and symptoms leading up to the death. The goal is to infer 
the likely causes of death from these data (Byass et al., 2012a). VA has been widely used by 
researchers in Health and Demographic Surveillance System (HDSS) sites, such as members 
of the INDEPTH Network (Sankoh and Byass, 2012) and the ALPHA Network (Maher et 
al., 2010), and has recently received renewed attention from the World Health Organization 
(WHO) through the release of an update to the widely-used WHO standard VA 
questionnaire (World Health Organization, 2012). The main statistical challenge with VA 
data is to ascertain patterns in responses that correspond to a pre-defined set of causes of 
death. Typically the nature of such patterns is not known a priori and measurements are 
subject to multiple types of measurement error, discussed below.
Multiple methods have been proposed to automate the assignment of cause of death from 
VA data. The Institute for Health Metrics and Evaluation (IHME) has proposed a number of 
methods (for example: Flaxman et al., 2011; James et al., 2011; Murray et al., 2011a). Many 
of these methods build on earlier work by King and Lu (King et al., 2010; King and Lu, 
2008). Altogether, this work has explored a variety of underlying statistical frameworks, 
although all are similar in their reliance on a so-called “gold standard” – a database 
consisting of a large number of deaths for which the cause has been certified by medical 
professionals and is considered reliable. Assuming the gold standard deaths are accurately 
labeled, methods in this class use information about the relationship between causes and 
symptoms from the gold standard deaths to infer causes for new deaths.
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Gold standard databases of this type are difficult and very expensive to create, and 
consequently most health researchers and policy makers do not have access to a good cause 
of death gold standard. Further it is often difficult to justify devoting medical professionals’ 
time to performing autopsies and chart reviews for deceased patients in situations with 
limited resources. Given these constraints, deaths included in a gold standard database are 
typically in-hospital deaths. In most of the places where VA is needed, many or most deaths 
occur in the home and are not comparable to in-hospital deaths. Further, the prevalence of 
disease changes dramatically through time and by region. In order to accurately reflect the 
relationship between VA data and causes of death, the gold standard would need to contain 
deaths from all regions through time; something that no existing gold standard does.
Recognizing the near impossibility of obtaining consistent gold standard databases that 
cover both time and space, we focus on developing a method to infer cause of death using 
VA data that does not require a gold standard. A method developed by Peter Byass known as 
InterVA (Byass et al., 2012a) has been used extensively, including by both the ALPHA and 
INDEPTH networks of HDSS sites, and is supported by the WHO. Rather than using gold 
standard deaths to inform the relationship between signs and symptoms and causes of death, 
InterVA uses information obtained from physicians in the form of ranked lists of signs and 
symptoms associated with each cause of death.
In this paper, we present a statistical method for assigning individual causes of death and 
population cause of death distributions using VA surveys in contexts where gold standard 
data are not available. In the remainder of this section we describe the current practice and 
three critical limitations. In Section 2 we propose a statistical model that addresses these 
three challenges and provides a flexible probabilistic framework that can incorporate the 
multiple types of data that are available in practice. Section 3 is the results section. Section 
3.1 presents results and comparison between the proposed method and existing alternatives 
using a gold standard dataset. Section 3.2 presents results from our method using data from 
two HDSS sites where no gold standard deaths are available. Section 4 describes how we 
incorporate physician assignment of cause of death. Although these data integrate naturally 
into our method, we present them in a separate section because they are only relevant when 
physician-coded causes are available. We end with Section 5 which provides a discussion of 
remaining limitations of VA data and proposes new directions for inquiry. Since many of the 
terms used in this paper are specific to the data and domain we discuss, we include a list of 
common acronyms in Table 1
1.2 InterVA and three issues
Given that InterVA is supported by the WHO and uses only information that is readily 
available in a broad range of circumstances, including those where there are no “gold 
standard” deaths, we focus our comparison on InterVA. When evaluating the performance of 
our method, we use multiple methods for comparison and provide detailed descriptions of 
the alternative methods in the Online Supplement. InterVA (Byass et al., 2012b) distributes a 
death across a pre-defined set of causes using information describing the relationship 
between VA data (signs and symptoms) and causes provided by physicians in a structured 
format. The complete details of the InterVA algorithm are not fully discussed in published 
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work, but they can be accurately recovered by examining the source code for the InterVA 
algorithm (Byass, 2012).
Consider data consisting of n individuals with observed set Si of (binary) indicators of 
symptoms, Si = {si1, si2, …, siS} and an indicator yi that denotes which one of C causes was 
responsible for person i’s death. Many deaths result from a complex combination of causes 
that is difficult to infer even under ideal circumstances. We consider this simplification, 
however, for the sake of producing demographic estimates of the fraction of deaths by cause, 
rather than for generating assignments that reflect the complexity of clinical presentations. 
The goal is to infer p(yi = c|Si) for each individual i and πc, the overall population cause 
specific mortality fraction (CSMF) for cause c, for all causes. Using Bayes’ rule,
(1)
InterVA obtains the numerator in (1) using information from interviews with a group of 
expert physicians. Many of the methods currently available, whether or not they use gold 
standard data, make use of this logic. That is, they rely on external input about the 
propensity of observing a particular symptom given the death was due to a particular cause. 
Some methods use Bayes’ rule directly (King and Lu (2008) uses Bayes’ rule on a set of 
randomly drawn causes, for example) while others apply different transformations to obtain 
a “propensity” for each cause given a set of symptoms (e.g. James et al. (2011)). The key 
distinction for InterVA is that, for each cause of death, a group of physicians with expertise 
in a specific local context provide a “tendency” of observing each sign/symptom, presented 
in Table 2. These tendencies are provided in a form similar to the familiar letter grade 
system used to indicate academic performance. These “letter grades”, the leftmost column in 
Table 2, effectively rank signs/symptoms by the tendency of observing them in conjunction 
with a given cause of death. These rankings are translated into probabilities to form a cause 
by symptom matrix, Ps|c. InterVA uses the translation given in Table 2. This transformation 
in Table 2 is arbitrary and, as we demonstrate through simulation studies in the Online 
Supplement, influential. Our proposed method uses only the ranking and infers probabilities 
as part of a hierarchical model. The probability p(Si|yi = c) in (1) is the joint probability of 
an individual experiencing a set of symptoms (e.g. experiencing a fever and vomiting, but 
not wasting). It is impractical to ask physicians about each combination of the hundreds of 
symptoms a person may experience. Apart from being impossibly time-consuming, many 
combinations are indistinguishable because most symptoms are irrelevant for any particular 
cause. InterVA addresses this by approximating the joint distribution of symptoms with the 
product of the marginal distribution for each symptom. That is, 
. This simplification is 
equivalent to assuming that the symptoms are conditionally independent given a cause, an 
assumption we believe is likely reasonable for many symptoms but discards valuable 
information in particular cases. We discuss this assumption further in subsequent sections in 
the context of obtaining more information from physicians in the future. This challenge is 
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not unique to our setting and also arises when using a gold standard dataset for a large set of 
symptoms. Most of the methods described above that use gold standard data utilize a similar 
simplification, but they derive the necessary p(Si|yi = c) empirically using the gold standard 
deaths (e.g. counting the fraction of deaths from cause c that contain a given symptom).
Three issues arise in the current implementation of InterVA. First, although the motivation 
for InterVA arises through Bayes’ rule, the implementation of the algorithm does not 
compute probabilities that are comparable across individuals. InterVA defines p(Si|yi = c) 
using only symptoms present for a given individual, that is p(Si|yi = c) ≜ ∏{j:sij=1} p(sij = 1|
yi = c). The propensity used by InterVA to assign causes is based only on the presence of 
signs/symptoms, disregarding them entirely when they are absent:
(2)
The expression in (2) ignores a substantial portion of the data, much of which could be 
beneficial in assigning a cause of death. Knowing that a person had a recent negative HIV 
test could help differentiate between HIV/AIDS and tuberculosis, for example. Using (2) 
also means that the definition of the propensity used to classify the death depends on the 
number of positive responses. If an individual reports a symptom, then InterVA computes 
the propensity of dying from a given cause conditional on that symptom. In contrast, if the 
respondent does not report a symptom, InterVA marginalizes over that symptom. Consider 
as an example the case where there are two symptoms si1 and si2. If a respondent reports the 
decedent experienced both, then InterVA assigns the propensity of cause c as p(yi = c|si1 = 1, 
si2 = 1). If the respondent only reports symptom 1, the propensity is p(yi = c ∩ si2 = 1|si1 = 
1) + p(yi = c ∩ si2 = 0|si1 = 1). These two measures represent fundamentally different 
quantities, so it is not possible to compare the propensity of a given cause across individuals.
Second, because the output of InterVA has a different meaning for each individual, it is 
impossible to construct valid measures of uncertainty for InterVA. We expect that even under 
the best circumstances there is variation in individuals’ presentation of symptoms for a given 
cause. In the context of VAs this variation is compounded by the added variability that arises 
from individuals’ ability to recollect and correctly identify signs/symptoms. Linguistic and 
ethnographic work to standardize the VA interview process could control and help quantify 
these biases, though it is not possible to eliminate them completely. Without a probabilistic 
framework, we cannot adjust the model for these sources of variation or provide results with 
appropriate uncertainty intervals. This issue arises in constructing both individual cause 
assignments and population CSMFs. The current procedure for computing CSMFs using 
InterVA aggregates individual cause assignments to form CSMFs (Byasset al., 2012a). This 
procedure does not account for variability in the reliability of the individual cause 
assignments, meaning that the same amount of information goes into the CSMF whether the 
individual cause assignment is very certain or little more than random guessing.
Third, the InterVA algorithm does not incorporate other potentially informative sources of 
information. VAs are carried out in a wide range of contexts with varying resources and 
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availability of additional data. For example, while true \gold standard” data are rarely 
available, many organizations already invest substantial resources in having physicians 
review at least a fraction of VAs and assign a cause based on their clinical expertise. 
Physicians reviewing VAs are able to assess the importance of multiple co-occurring 
symptoms in ways that are not possible with current algorithmic approaches, and because of 
that, physician-assigned causes are a potentially valuable source of information.
In this paper, we develop a new method for estimating population CSMFs and individual 
cause assignments, InSilicoVA, that addresses the three issues described above. Critically, 
the method is modular. At the core of the method is a general probabilistic framework. On 
top of this exible framework we can incorporate multiple types of information, depending on 
what is available in a particular context. In the case of physician coded VAs, for example, we 
propose a method that incorporates physician expertise while also adjusting for biases that 
arise from their different clinical experiences.
2 InSilicoVA
This section presents a hierarchical model for cause-of-death assignment, known as 
InSilicoVA. This model addresses the three issues that currently limit the effectiveness of 
InterVA and provides a flexible base that incorporates multiple sources of uncertainty. We 
intend this method for use in situations where access to \gold standard” data is not possible 
and, as such, there are no labeled outcomes and we cannot leverage a traditional supervised 
learning framework. Section 2.1 presents our modeling framework. We then present the 
sampling algorithm in Section 2.2.
2.1 Modeling framework
This section presents the InSilicoVA model, a hierarchical Bayesian framework for inferring 
individual cause of death and population cause distributions. A key feature of the InSilicoVA 
framework is sharing information between inferred individual causes and population cause 
distributions. As in the previous section, let yi = {1,…,C} be the cause of death indicator for 
a given individual i and the vector Si = {si1, si2,…,siS} be signs/symptoms. We begin by 
considering the case where we have only VA survey data and will address the case with 
physician coding subsequently. We typically have two pieces of information: (i) an 
individual’s signs/symptoms, sij and (ii) a matrix of conditional probabilities, Ps|c. The Ps|c 
matrix describes a ranking of signs/symptoms given a particular cause.
We begin by assuming that individuals report symptoms as independent draws from a 
Bernoulli distribution given a particular cause of death c. That is,
where P(sij|yi = c) are the elements of Ps|c corresponding to the given cause. The assumption 
that symptoms are independent is likely violated, in some cases even conditional on the 
cause of death. Existing techniques for eliciting the Ps|c matrix do not provide information 
about the association between two (or more) signs/symptoms occurring together for each 
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cause, however, making it impossible to estimate these associations. Since yi is not observed 
for any individual, we treat it as a random variable. Specifically,
where π1,…,πC are the population cause-specific mortality fractions.
Without gold standard data, we rely on the Ps|c matrix to understand the likelihood of a 
symptom profile given a particular cause. In practice physicians provide only a ranking of 
likely signs/symptoms given a particular cause. Rather than arbitrarily assigning 
probabilities to each sign/symptom in a particular ordering, as in Table 2, we learn those 
probabilities. We could model each element of Ps|c using this expert information to ensure 
that, within each cause, symptoms with higher labels in Table 2 have higher probability. 
Since many symptoms are uncommon, this strategy would require estimating multiple 
probabilities with very weak (or no signal) in the data. Instead we estimate a probability for 
every letter grade in Table 2. This strategy requires estimating substantially fewer parameters 
and imposes a uniform scale across conditions. Entries in the Ps|c matrix are not individual 
specific; therefore, we drop the i indicator and refer to a particular symptom sj and entries in 
Ps|c as p(sj|y = c). Following Taylor et al. (2007), we re-parameterize Ps|c as PL(s|c), where 
L(s|c) indicates the letter ranking of the (s, c)-th cell in the Ps|c matrix based on the expert 
opinion provided by physicians in Table 2. We then give each entry in PL(s|c) a truncated 
Beta prior:
where M and αs|c are prior hyperparameters and are chosen so that αs|c/M gives the desired 
prior mean for PL(s|c), and the constraint represents the truncation imposed by the order of 
the ranked probabilities. For simplicity, we use 𝟙s|c to represent an indicator of the interval 
where PL(s|c) is defined. That is, 𝟙s|c defines the portion of a beta distribution between the 
symptoms with the next largest and next smallest probabilities,
This strategy uses only the ranking (encoded through the letters in the table) and does not 
make use of arbitrarily assigned numeric values, as in InterVA. Our strategy imposes a strict 
ordering over the entries of Ps|c. We could instead use a stochastic ordering by eliminating 
𝟙s|c in the above expression. Defining the size of αs|c in an order consistent with the expert 
opinion in Table 2 would encourage, but not require, the elements of Ps|c to be consistent 
with expert rankings. We find this approach appealing conceptually, but not compatible with 
the current strategy for eliciting expert opinion. In particular, there are likely entries in Ps|c 
that are difficult for experts to distinguish. In these cases it would be appealing to allow the 
method to infer which of these close probabilities is actually larger. Current strategies for 
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obtaining Ps|c from experts, however, do not offer experts the opportunity to report 
uncertainty, making it difficult to appropriately assign uncertainty in the prior distribution.
We turn now to the prior distribution over population CSMF’s, π1,…,πC. Placing a Dirichlet 
prior on the vector of population CSMF probabilities would be computationally efficient 
because of Dirichlet-Multinomial conjugacy. However in our experience it is difficult to 
explain to practitioners and public health officials the intuition behind the Dirichlet 
hyperparameter. Moreover, in many cases we can obtain a reasonably informed prior about 
the CSMF distribution from local public health officials. Thus, we opt for an over-
parameterized normal prior (Gelman et al., 1996) on the population CSMFs. This prior 
representation does not enjoy the same benefits of conjugacy but is more interpretable and 
facilitates including prior knowledge about the relative sizes of CSMFs. Specifically we 
model πc = exp θc/Σc exp θc where each θc has an independent Gaussian distribution with 
mean μ and variance σ2. We put diffuse uniform priors on μ and σ2. To see how this 
facilitates interpretability, consider a case where more external data exists for communicable 
compared to non-communicable diseases. Then, the prior variance can be separated for 
communicable and non-communicable diseases to represent the different amounts of prior 
information. The model formulation described above yields the following posterior:
To contextualize our work, we can relate it to Latent Dirichlet Allocation (LDA) and other 
text mining approaches to finding relationships between binary features. To compare 
InSilicoVA to LDA, consider CSMFs as topics, conditions as words, and cases as 
documents. InSilicoVA and LDA are similar in that we may consider each death as resulting 
from a combination of causes, just as LDA considers each document to be made up of a 
combination of topics. Further, each cause in InSilicoVA is associated with a particular set 
of observed conditions, while in LDA each topic is associated with certain words. The 
methods differ, however, in their treatment of topics (causes) and use of external information 
in assigning words (conditions) with documents (deaths). Unlike LDA where topics are 
learned from patterns in the data, InSilicoVA is explicitly interested in inferring the 
distribution of a pre-defined set of causes of death. InsilicoVA also relies on external 
information, namely the matrix of conditional probabilities Ps|c to associate symptoms with 
a given cause. Statistically, this amounts to estimating a distribution of causes across all 
deaths, then using the matrix of conditional probabilities to infer the likely cause for each 
death, given a set of symptoms. This means that each death arises as a mixture over causes, 
but inference about this distribution depends on both the pattern of observed signs/symptoms 
and the matrix of conditional probabilities. In LDA, each document has a distribution over 
topics that is learned only from patterns of co-appearance between words. We also note that 
the prior structure differs significantly from LDA to accomplish the distinct goals of VA.
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2.2 Sampling from the posterior
This section provides the details of our sampling algorithm. We evaluated this algorithm 
through a series of simulation and parameter recovery experiments. Additional details 
regarding this process are in the Online Supplement. All codes are written in R (R Core 
Team, 2014), with heavy computation done through calls to Java using rJava (Urbanek, 
2009). We have prepared an R package which we have included with our resubmission and 
will submit the package to CRAN prior to publication.
2.2.1 Metropolis-within-Gibbs algorithm—The posterior in the previous section is not 
available in closed form. We obtain posterior samples using Markov-chain Monte Carlo, 
specifically the Metropolis-within-Gibbs algorithm described below. We first give an 
overview of the entire procedure and then explain the truncated beta updating step in detail. 
Given suitable initialization values, the sampling algorithm proceeds:
1. Sample Ps|c from truncated beta step described in the following section.
2. Generate Y values using the Naive Bayes Classifier, that is for person i
where
3. Update π⃗
a. Sample μ
b. Sample σ2
c. Sample θ⃗
This needs to be done using a Metropolis Hastings step: 
for k in 1 to C,
• Sample U ~ Uniform(0, 1)
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• Sample θ⃗* ~ N(θ⃗, σ*),
•
If , then 
update θk by .
We find computation time to be reasonable even for datasets with ~ 105 deaths. We provide 
additional details about assessing convergence in the results section and Online Supplement.
2.2.2 Truncated beta step—As described in the previous section, our goal is to estimate 
probabilities in Ps|c for each ranking given by experts (the letters in Table 2). We denote the 
levels of Ps|c as L(s|c) and, assuming the prior from the previous section, sample the full 
conditional probabilities under the assumption that all entries with the same level in Ps|c still 
share the same value. Denoting the probability for a given ranking or tier as Pt(si|cj), the full 
constraints become:
The full conditionals are then truncated beta distributions with these constraints, defined as:
where M and αLsj|ckare hyperparameters and y⃗ is the vector of causes at a given iteration. 
The 1S|c term defines an indicator function which we denote as short hand for 
1PL(s|c)∈(PL(s|c)−1,PL(s|c)+1). That is, 1S|c denotes the indicator for whether the level for a 
particular s|c falls between the upper and lower bounds of that level. We incorporate these 
full conditionals into the sampling framework above, updating the truncation at each 
iteration according to the current values of the relevant parameters.
3 Results
In this section we present results from our method in two contexts. First, in Section 3.1 we 
compare our method to alternative approaches using a set of gold standard deaths. For these 
results, we compared our method to both InterVA and to methods currently used in practice 
when gold standard deaths are available. Then, in Section 3.2 we implement our method 
using data from two health and surveillance sites.
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Along with the results presented in the remainder of this section, we also performed 
simulation studies to understand our method’s range of performance. Details and results of 
these simulations are presented in the Online Supplement.
3.1 PHMRC gold standard data
We compare the performance of multiple methods using the Population Health Medical 
Research Consortium (PHMRC) dataset (Murray et al., 2011b). The PHMRC dataset 
consists of about 7,000 deaths recorded in six sites across four countries (Andhra Pradesh, 
India; Bohol, Philippines; Dar es Salaam, Tanzania; Mexico City, Mexico; Pemba Island, 
Tanzania; and Uttar Pradesh, India). Gold standard causes are assigned using a set of 
specific diagnostic criteria that use laboratory, pathology, and medical imaging findings. All 
deaths occurred in a health facility. For each death, a blinded verbal autopsy was also 
conducted.
To evaluate the performance of InSilicoVA, we compared our proposed method to a number 
of alternative algorithmic and probabilistic methods. Specifically, we examined Tariff (James 
et al., 2011), the approach proposed by King and Lu (2008), the Simplified Symptom Pattern 
Method (Murray et al., 2011a) and InterVA. We provide a short description of each 
comparison method along with complete details of our implementation in the Online 
Supplement. The most realistic comparator to our method is InterVA, since InterVA is the 
only method currently available that does not require gold standard training data. For both 
InterVA and InSilicoVA, we use the training data to extract a matrix of ranks that used to 
estimate a Ps|c matrix. In practice, these values would come from input provided by experts. 
Through simulation studies provided in the Online Supplement, we show that the quality of 
inputs greatly inuences performance of all methods. With the PHMRC data we use the 
labeled deaths to generate inputs for all of the methods, separating the performance of the 
statistical model or algorithm from the quality of inputs.
We calculate the raw conditional probability matrix of each symptom given a cause, then 
used two approaches to construct the rank matrix from the empirical values required for 
InterVA and InSilicoVA. First, we ranked the conditional probabilities using 15 levels and a 
distribution matching the InterVA model. For example, if a% of the cells in the original 
InterVA Ps|c matrix are assigned the lowest level, we assign also a% of the cells in the 
empirical matrix to be that level. We assign the median value among these cells to be the 
default value for this level. We refer to this first approach as the “Quantile prior” since it 
preserves the same distribution of probabilities in the InterVA matrix. Second, we ranked the 
probabilities using the same levels in Table 2 by assigning each cell the letter grade in Table 
2 with value closest to it. We refer to this approach as the “Default prior” since it uses the 
same translation between empirical probabilities and ranks as in InterVA.
In examining the results, note that SSP does not provide CSMF estimates. King et al. (2010) 
provides a method for classifying individual deaths using the framework from King and Lu 
(2008), but this method has not been empirically evaluated and is not widely used in 
practice, so we do not include it in our comparison study. The King and Lu (2008) method 
also allows advanced users to tune the number of symptoms sampled in their procedure. We 
implement the method using a value close to the default parameter. For the individual cause 
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assignment we also evaluated performance using the Chance-Corrected Concordance metric 
proposed by Murray et al. (2014). Results using this metric were substantively similar, with 
the exception that the Tariff method’s performance decreases when viewed with this metric. 
Complete results with chance-corrected concordance are presented in the Online 
Supplement.
We evaluated out of sample performance in two ways. Before considering these results, we 
note that InSilicoVA and InterVA use less information from the data than the comparison 
methods. In each comparison, the methods designed for gold standard data have access to all 
available information in the training set, whereas InSilicoVA and InterVA only have access 
to the ranked likelihood of seeing a symptom for a given cause.
In our first evaluation, we obtained training sets by simply sampling each death with equal 
probability. This is the most straightforward approach to derive test-train splits and produces 
a CSMF distribution that matches the data. Figure 1 displays the results across 100 test-train 
splits. A striking first result is the unparalleled performance of the King and Lu (2008) 
method. The King and Lu (2008) relies on randomly selected samples of symptoms taken 
from the training set to produce estimates for the elements of Ps|c that can then be applied to 
the test set. In theory, King and Lu (2008) method only requires that the estimated elements 
of Ps|c obtained from the training sample be applicable in the test sample. In practice, 
however, if certain symptom combinations appear more (or less) frequently in the training 
set than the testing set, then the random sampling of symptoms will introduce additional 
error in the Ps|c estimates. Taking a simple random sample of PHMRC deaths to use as 
testing means that the distribution of symptom occurrence is, in expectation, very similar 
between training and testing sets. These conditions underestimate the potential for error in 
estimating elements of Ps|c. Additional simulation results for the King and Lu (2008) 
method are in the Online Supplement. Aside from this caveat, InSilicoVA displays superior 
performance in both CSMF distribution and individual cause assignments. The two ways of 
computing Ps|c make little difference in the performance, indicating that the model can 
recover reasonable estimates of Ps|c entries even when ranks are constructed in different 
ways.
For our second PHMRC evaluation study, we use the test/training split approach proposed 
by Murray et al. (2011b). Using this approach, the dataset is first randomly split into testing 
and training sets. For the testing set, a cause of death distribution is simulated from a 
Dirichlet distribution at each iteration. Cases from the testing set are then sampled with 
replacement with probability proportional to the simulated CSMF. This approach allows the 
“true” cause of death distribution to change at each iteration, meaning that results are not 
specific to a single cause of death distribution. A downside of this re-sampling approach, 
however, is that the implementation proposed by Murray et al. (2011b) uses a diffuse 
Dirichlet distribution, meaning that the cause of death distribution is typically at across 
causes. In practice, the data we use display large variation in the cause of death distributions, 
with a small number of causes accounting for most of the deaths.
Figure 2 displays the results for the Dirichlet assignment evaluation. There is greater 
variability in performance among all methods compared to Figure 1, though InSilicoVA 
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displays superior performance in both CSMF and individual cause assignment. As expected, 
the added variability between the testing and training symptom profiles introduces additional 
error in the King and Lu (2008) method, resulting in reduced performance. To better 
understand how the methods perform on specific causes, Figure 3 shows a confusion matrix 
for the Dirichlet resampling evaluation study. The diagonals in the confusion matrices 
represent the number of times the method correctly identifies a cause X across 100 
simulations, divided by the number of times across the 100 test-train splits that cause X was 
the true cause. The off-diagonal elements give the fraction of times the method incorrectly 
identifies cause X as the true cause across the test-train splits. For InSilicoVA and InterVA 
we show 21 results for the default (InterVA cutoffs) prior, though the results for the quantile 
prior were substantively similar. We see the best performance from InSilicoVA and Tariff. 
Note also that many of the cases involving misclassification in all of the methods occur 
where there are related causes. HIV/AIDs and Tuberculosis (TB) are frequently 
misclassified, for example. Many cancers are also dificult to differentiate from one-another, 
as we see off-diagonal shading in the lower center and right of the plots. We provide further 
results in the Online Supplement, including tables giving sensitivity and specificity for each 
method and cause.
Throughout this work, we claim that gold standard data are rarely available in practice. One 
may question, however, why we cannot simply use the PHMRC data as a gold standard 
dataset in future applications. To evaluate this question, we exploit the geographic variability 
within the PHMRC data. We used the data from one of the PHMRC sites as the testing set, 
then used as the training set: (1) all the sites, (2) all other sites, (3) the same site and (4) one 
of the other sites. The results are summarized in Tables 3 and 4. We show additional results 
in the Online Supplement that reveal performance for each site as training data individually. 
In almost every case InSilicoVA outperforms all other methods in terms of both mean CSMF 
accuracy and mean COD assignment accuracy. The only exception is when using one site as 
training and a different site as testing, where King and Lu (2008) has slightly higher average 
CSMF accuracy. We see a noticeable decrease in performance when training using a site that 
is different from the testing region. The probabilistic structure underlying InSilicoVA and 
using only the conditional probabilities given in the Ps|c matrix mitigate this effect, though 
we still see a performance drop. This indicates that both the distribution of causes of death 
and that the association between symptoms and causes change based on geographic 
variability. In contrast to the resources required to collect gold standard data, the Ps|c matrix 
used by InterVA and InSilicoVA can be collected cheaply and effciently and tailored to the 
specific symptom/cause relationship in a particular geographic setting.
3.2 HDSS sites
In this section we present results comparing InSilicoVA and InterVA using VA data from 
two Health and Demographic Surveillance Sites (HDSS). Section 3.2.1 provides background 
information to contextualize the diverse environments of the two sites, and Section 3.2.2 
presents the results.
3.2.1 Background: Agincourt and Karonga sites—We apply both methods to VA 
data from two HDSS sites: the Agincourt health and sociodemographic surveillance system 
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(Kahn et al., 2012) and the Karonga health and demographic surveillance system (Crampin 
et al., 2012). Both sites collect VA data as the primary means of understanding the 
distribution and dynamics of cause of death. As is typically the case in circumstances where 
VAs are used, the VA data at these sites are not validated by physicians performing physical 
autopsies. We do not, therefore, have gold standard data we can leverage for training 
methods.
The Agincourt site continuously monitors the population of about 31 villages located in the 
Bushbuckridge subdistrict of Ehlanzeni District, Mpumalanga Province in northeast South 
Africa. This is a rural population living in what was during Apartheid a black “homeland,” 
or Bantustan. The Agincourt HDSS was established in the early 1990s to guide the 
reorganization of South Africa’s health system. Since then the site has functioned 
continuously and its purpose has evolved so that it now conducts health intervention trials 
and contributes to the formulation and evaluation of health policy. The population covered 
by the site is approximately 120,000 and vital events including deaths are updated annually. 
VA interviews are conducted on every death occurring within the study population. We use 
9,875 adult deaths from Agincourt from people of both sexes from 1993 to the present.
The Karonga site monitors a population of about 35,000 in northern Malawi near the port 
village of Chilumba. The current system began with a baseline census from 2002–2004 and 
has maintained continuous demographic surveillance. The Karonga site is actively involved 
in research on HIV, TB, and behavioral studies related to disease transmission. Similar to 
Agincourt, VA interviews are conducted on all deaths, and this work uses 1,469 adult deaths 
from Karonga that have occurred in people of both sexes from 2002 to the present.
3.2.2 Results for HDSS sites—We fit InSilicoVA to VA data from both Agincourt and 
Karonga. We also fit InterVA using the physician-generated conditional probabilities Ps|c as 
in Table 2 and the same prior CSMFs π⃗ provided by the InterVA software (Byass, 2013). We 
removed external causes (e.g., suicide, traffic accident, etc.) because deaths from external 
causes usually have very strong signal indicators and are usually less dependent on other 
symptoms. For InterVA, we first removed the deaths clearly from external causes and use the 
R package InterVA4 (Li et al., 2014) to obtain CSMF estimates. For InSilicoVA, we ran 
three MCMC chains with different starting points. For each chain, we ran the sampler for 
104 iterations, discarded the first 5, 000, and then thinned the chain using every twentieth 
iteration. We ran the model in R and it took about 15 minutes for Agincourt data and less 
than 5 minutes for Karonga using a standard desktop machine. Visual inspection suggested 
good mixing and we assessed convergence using Gelman-Rubin (Gelman and Rubin, 1992) 
tests. Complete details of our convergence checks are provided in the Online Supplement.
The results from Agincourt and Karonga study are presented in Figure 4. InSilicoVA is far 
more conservative and produces confidence bounds, whereas InterVA does not. A key 
difference is that InSilicoVA classifies a larger portion of deaths to causes labeled in various 
“other” groups. This indicates that these causes are related to either communicable or non-
communicable diseases, but there is not enough information to make a more specific 
classification. This feature of InSilicoVA identifies cases that are dificult to classify using 
available data and may be good candidates for additional attention, such as physician review.
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We view this behavior as a strength of InSilicoVA because it is consistent with the 
fundamental weakness of the VA approach, namely that both the information obtained from 
a VA interview and the expert knowledge and/or gold standard used to characterize the 
relationship between signs/symptoms and causes are inherently weak and incomplete, and 
consequently it is very dificult or impossible to make highly specific cause assignments 
using VA. Given this, we do not want a method that is artificially precise, i.e. forces fine-
tuned classification when there is insuficient information. Hence we view InSilicoVA’s 
behavior as reasonable, “honest” (in that it does not over interpret the data) and useful. 
“Useful” in the sense that it identifies where our information is particularly weak and 
therefore where we need to apply more effort either to data or to interpretation.
4 Physician coding
The information available across contexts that use VA varies widely. One common source of 
external information arises when a team of physicians reviews VA data and assigns a likely 
cause to each death. Since this process places additional demands on already scarce 
physician time, it is only available for some deaths. Unlike a gold standard dataset where 
physician information is used as training data for an algorithm, a physician code is typically 
used as the definitive classification. Physician clarifiers do not have access to the decedent’s 
body to perform a more detailed physical examination, as in a traditional autopsy.
We propose incorporating physician coded deaths into our hierarchical modeling framework. 
This strategy provides a unified inference framework for population cause distributions 
based on both physician coded and non-physician coded deaths. We address two challenges 
in incorporating these additional sources of data. First, available physician coded data often 
do not match causes used in existing automated VA tools such as InterVA. For example in 
the Karonga HDSS site physicians code deaths in a list of 88 categories and need to be 
aggregated into broader causes to match InterVA causes. Second, each physician uses her/his 
own clinical experience, and often a sense of context-specific disease prevalences, to code 
deaths, leading to variability and potentially bias. In Section 4.1 we present our approach to 
addressing these two issues. We then present results in Section 4.2.
4.1 Physician coding framework
In this section we demonstrate how to incorporate physician coding into the InSilicoVA 
method. If each death were coded by a single physician using the same possible causes of 
death as in our statistical approach, the most straightforward means of incorporating this 
information would be to replace the yi for a given individual with the physician’s code. This 
strategy assumes that a physician can perfectly code each death using the information in a 
VA interview. In practice it is difficult for physicians to definitively assign a cause using the 
limited information from a VA interview. Multiple physicians typically code each death to 
form a consensus. Further the possible causes used by physicians do not match the causes 
used in existing automated methods. In the data we use, physicians first code based on six 
broad cause categories, then assign deaths to more specific subcategories. Since we wish to 
use clinician codes as an input into our probabilistic model rather than as a final cause 
determination, we will use the broad categories from the Karonga site. Since our data are 
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only for adults we removed the category “infant deaths.” We are also particularly interested 
in assignment in large disease categories, such as TB or HIV/AIDS, so we add and 
additional category for these causes. The resulting list is: (i) non-communicable disease 
(NCD), (ii) TB or AIDS, (iii) other communicable disease, (iv) maternal cause, (v) external 
cause or (vi) unknown. The WHO VA standards (World Health Organization, 2012) map the 
causes of death used in the previous section to ICD-10 codes, which can then be associated 
with these six broad categories. We now have a set of broad cause categories {1, …, G} that 
physicians use and a way to relate these general causes to several causes of death used by 
InSilicoVA.
We further assume that we know the probability that a death is related to a cause in each of 
these broad cause categories. That is, we have a vector of a rough COD distribution for each 
death: Zi = (zi1, …, ziG) and Σg zig = 1. In situations where each death is examined by 
several physicians, we can use the distribution of assigned causes across the physicians. 
When only one physician reviews the death, we place all the mass on the Zi term 
representing the broad category assigned by that one physician. An advantage of our 
Bayesian approach is that we could also distribute mass across other cause categories if we 
had additional uncertainty measures. We further add a latent variable ηi ∈ {1, …, G} 
indicating the category assignment. The posterior of Y then becomes
Since ηi = g|Zi ~ Categorical(zi1, zi2, …, ziG) and yi|π, 
 where , and χcg is the indicator of 
cause k in category g. Without loss of generality we assume each cause belongs to at least 
one category. Then by collapsing the latent variable ηi, we directly sample yi from the 
posterior distribution:
where
A certain level of physician bias is inevitable, especially when physicians’ training, 
exposure, and speciality vary. Some physicians are more likely to code certain causes than 
others, particularly where they have clinical experience in the setting and a presumed 
knowledge of underlying disease prevalences. We adopt a two-stage model to incorporate 
uncertainties in the data and likely bias in the physician codes. First we use a separate model 
to estimate the bias of the physician codes and obtain the de-biased cause distribution for 
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each death. Then, we feed the distribution of likely cause categories (accounting for 
potential bias) into InsilicoVA to guide the algorithm.
For the first stage we used the model for annotation bias in document classification proposed 
by Salter-Townshend and Murphy (2013). The algorithm was proposed to model the 
annotator bias in rating news sentiment, but if we think of each death as a document with 
symptoms as words and cause of death as the sentiment categories, the algorithm can be 
directly applied to VA data with physician coding. Suppose there are M physicians in total, 
and for each death i there are Mi physicians coding the cause. Let 
 be the code of death i by physician m, where  if death i 
is assigned to cause g and 0 otherwise. The reporting bias matrix  for each physician 
is then defined as the probability of assigning cause g′ when the true cause is g. If we also 
denote the binary indicator of true cause of death i to be Ti = {ti1, ti2, …, tiG}, the 
conditional probability of observing symptom j given cause g as pj|g, and the marginal 
probability of cause g as πg, then the complete data likelihood of physician coded dataset is:
(3)
We then proceed as in Salter-Townshend and Murphy (2013) and learn the most likely set of 
parameters through an implementation of the EM algorithm. The algorithm proceeds:
1. For i = 1, …, n:
a.
initialize T using 
b. initialize π using 
2. Repeal until convergence:
After convergence, the estimator t̂ig can then be used in place of zig in the main algorithm as 
discussed in Section 2.1. An alternative would be to develop a fully Bayesian strategy to 
address bias in physician coding. We have chosen not to do this because the VA data we 
have is usually interpreted by a small number of physicians who assign causes to a large 
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number of deaths. Consequently there is a large amount of information about the specific 
tendencies of each physician, and thus the physician-specific bias matrix can be estimated 
with limited uncertainty. A fully Bayesian approach would involve estimating many 
additional parameters, but sharing information would be of limited value because there are 
many cases available to estimate the physician-specific matrix. We believe the uncertainty in 
estimating the physician-specific matrix is very small compared to other sources of 
uncertainty.
4.2 Comparing results using physician coding
We turn now to results that incorporate physician coding. We implemented the physician 
coding algorithm described above on the Karonga dataset described in Section 3.2.1. The 
Karonga site has used physician and clinical officer coding from 2002 to the present. The 
1,469 deaths in our data have each been reviewed by physician. Typically each death is 
reviewed by two physicians; deaths where the two disagree are reviewed by a third. Over the 
period of this analysis, 18 physicians reviewed an average of 217 deaths each.
We first evaluate the difference in CSMFs estimated with and without incorporating 
physician-coded causes. We use the six broad categories of physician coding described in 
Section 4.1. Figure 5 compares the CSMFs using InSilicoVA both with and without 
physician coding. Including physician coding reduces the fraction of deaths coded as other/
unspecified infectious diseases and increases the fraction of deaths assigned to HIV/AIDS. 
This is likely the result of physicians with local knowledge being more aware of the 
complete symptom profile typically associated with HIV/AIDS in their area. They may also 
gather useful data from the VA narrative that aids them in making a decision on cause of 
death. Having seen multiple cases of HIV/AIDS, physicians can leverage information from 
combinations of symptoms that is much harder to build into a computational algorithm. 
Physicians can also use knowledge of the prevalence of a given condition in a local context. 
If the majority of deaths they see are related to HIV/AIDS, they may be more likely to 
assign HIV/AIDS as a cause even in patients with a more general symptom profile.
Figure 6 shows the estimated physician-specific bias matrices for the nine physicians coding 
the most deaths. Since each physician has unique training and experience, we expect that 
there will be differences between physicians in the propensity to assign a particular cause, 
even among physicians working in the same clinical context. Figure 6 displays the 
matrix described in Section 4.1. The shading of each cell in the matrix represents the 
propensity of a given physician to code a death as the cause category associated with its row, 
given that the true cause category is the cause category associated with its column. If all 
physicians coded with no individual variation, all of the blocks would be solid black along 
the diagonal. Figure 6 shows that there is substantial variability between the physicians in 
terms of the degree of their individual proclivity to code specific causes. This variation is 
especially persistent in terms of non-communicable diseases, indicating that physicians’ 
unique experiences were most influential in assigning non-communicable diseases.
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5 Discussion
Assigning a cause(s) to a particular death can be challenging under the best circumstances. 
Inferring a cause(s) given the limited data available from sources like VA in many 
developing nations is an extremely difficult task. In this paper we propose a probabilistic 
statistical framework for using VA data to infer an individual’s cause of death and the 
population cause of death distribution and quantifying uncertainty in both. The proposed 
method uses a data augmentation approach to reconcile individuals’ causes of death with the 
population cause of death distribution. We demonstrate how our new framework can 
incorporate multiple types of outside information, in particular physician codes. However, 
many open issues remain. In our data, we observe all deaths in the HDSS site. Inferring 
cause of death distributions at a national or regional level, however, would require an 
adjustment for sampling. If sampling weights were known, we could incorporate them into 
our modeling framework. In many developing nations, however, there is limited information 
available to construct such weights.
In practice, the proposed method is intended for situations where “gold standard” death are 
not available and where priors have been elicited from medical experts in the form of the 
matrix of conditional probabilities Ps|c. The method is also suitable for situations where 
there is partial physician coding, especially in situations where the same physician codes a 
large number of VA surveys. Through our evaluation experiments using the PHMRC gold 
standard dataset, we also now suggest that the Ps|c matrix should be updated to reflect 
regional and temporal changes in symptom-cause associations.
We conclude by highlighting two additional open questions. For both we stress the 
importance of pairing statistical models with data collection. First, questions remain about 
the importance of correlation between symptoms in inferring a given cause. In both 
InSilicoVA and InterVA the product of the marginal probability of each cause is used to 
approximate the joint distribution of the entire vector of a decedent’s symptoms. This 
assumption ignores potentially very informative information about comorbidity between 
signs/symptoms, i.e. dependence in the manifestation of signs/symptoms. Physician 
diagnosis often relies on recognition of a constellation of signs and symptoms combined 
with absence of others. Advances in statistical tools for modeling large covariance matrices 
through factorizations or projections could provide ways to model these interactions. 
Information describing these dependencies needs to be present in Ps|c, the matrix of 
conditional probabilities associating signs/symptoms and causes elicited from physicians. 
Until now physicians have not been asked to produce this type of information and there does 
not exist an appropriate data collection mechanism to do this. When producing the Ps|c 
matrix, medical experts are only asked to provide information about one cause at a time. 
Obtaining information about potentially informative co-occurences of signs/symptoms is 
essential but will involve non-trivial changes to future data collection efforts. It is practically 
impossible to ask physicians about every possible combination of symptoms. A key 
challenge, therefore, will be identifying which combinations of symptoms could be useful 
and incorporating this incomplete association information into our statistical framework. 
The Ps|c matrix entries are also currently solicited by consensus and without uncertainty. 
Adding uncertainty is straightforward in our Bayesian framework and would produce more 
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realistic estimates of uncertainty for the resulting cause assignment and population 
proportion estimates.
Second, the current VA questionnaire is quite extensive and requires a great deal of time, 
concentration and patience to administer. This burden is exacerbated since interviewees have 
recently experienced the death of a loved one or close friend. Further, many symptoms occur 
either very infrequently or extremely frequently across multiple causes of death. Reducing 
the number of items on the VA questionnaire would ease the burden on respondents and 
interviewers. This change would likely improve the overall quality of the data, allowing 
individuals to focus more on the most influential symptoms without spending time on 
questions that are less informative. Reducing the number of items on the questionnaire and 
prioritizing the remaining items would accomplish this goal. Together the increasing 
availability of affordable mobile survey technologies and advances in item-response theory, 
related areas in statistics, machine learning, and psychometrics provide an opportunity to 
create a more parsimonious questionnaire that dynamically presents a personalized series of 
questions to each respondent based on their responses to previous questions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Comparison using random splits
Results across 100 test-train splits using a randomly sampled 25% of deaths as the test set. 
InSilicoVA demonstrates good performance for both population cause distribution and 
individual assignment.
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Figure 2. Comparison using random splits and re-sampled test set
Performance over 100 simulations using the test-train splitting approach proposed by 
Murray et al. (2011b). The Dirichlet sampling approach used by the Murray et al. (2011b) 
method produces testing sets that do not necessarily have CSMF distributions similar to the 
training set. InSilicoVA again demonstrates substantial performance improvements.
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Figure 3. Confusion matrices
Confusion matrix for four methods, with InSilicoVA and InterVA using the default prior. 
Shading on the diagonal represents the fraction of correct classifications across 100 test-train 
splits using the Dirichlet resampling strategy; Off-diagional shading represents the fraction 
of misclassifcations.
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Figure 4. The 10 largest CSMFs
Estimation comparing InsilicoVA to InterVA in two HDSS sites. Overall we see that 
InSilicoVA classifies a larger proportion of deaths into ‘other/unspecified’ categories, 
reecting a more conservative procedure that is consistent with the vast uncertainty in these 
data. Point estimates represent the posterior mean and intervals are 95% credible intervals.
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Figure 5. The top 10 most different CSMFs
Estimation comparing InterVA with and without physician coding for the Karonga dataset. 
InSilicoVA without physician coding categorizes many more deaths as ‘Other and 
unspecified infectious diseases’ compared to InterVA. Including physician coding reduces 
the fraction of deaths in this category, indicating an increase in certainty about some deaths. 
Point estimates represent the posterior mean and intervals are 95% credible intervals.
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Figure 6. Physician variability
Each 6 × 6 square matrix represents a single physician coding verbal autopsy deaths from 
the Karonga HDSS. Within each matrix, the shading of each cell corresponds to the 
propensity of the physician to classify the death into the cause category associated with the 
cell’s row when the the true cause category is the one associated with the cell’s column. The 
physician bias estimates come from comparing cause assignments for the same death 
produced by multiple physicians. A physician with no individual bias would have solid black 
on the diagonal. The figure indicates that the variation in both the nature and magnitude of 
individual physician bias varies substantially between physicians.
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Table 1
List of common global health abbreviations used in this paper.
Acronym Meaning
CSMF Cause-specific mortality fraction
COD Cause of death
HDSS Health & demographic surveillance system
PHMRC Population Health Medical Research Consortium
VA Verbal autopsy
WHO World Health Organization
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Table 2
InterVA Conditional Probability Letter-Value Correspondences from Byass et al. (2012b).
Label Value Interpretation
I 1.0 Always
A+ 0.8 Almost always
A 0.5 Common
A− 0.2
B+ 0.1 Often
B 0.05
B− 0.02
C+ 0.01 Unusual
C 0.005
C− 0.002
D+ 0.001 vRare
D 0.0005
D− 0.0001
E 0.00001 Hardly ever
N 0.0 Never
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